| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $41.69B | $41.53B | $43.45B |
| YoY Revenue Growth % | +0.4% | -4.4% | — |
| Gross Profit | $9.37B | $9.38B | — |
| Gross Margin % | 22.5% | 22.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.39B | $1.26B | $1.57B |
| Operating Margin % | 3.3% | 3.0% | 3.6% |
| Net Income (GAAP) | $1.07B | $927.0M | $1.24B |
| EBITDA (Normalized) | $1.95B | $1.83B | $3.14B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.96B | $2.10B | $1.47B |
| Capital Expenditures (CapEx) | $704.0M | $706.0M | $1.96B |
| Free Cash Flow (FCF) | $1.26B | $1.39B | -$485.3M |
| FCF Margin % | 3.0% | 3.4% | -1.1% |
| Return on Invested Capital (ROIC %) | 23.6% | 42.0% | 3.9% |
| Cash & Short-Term Equivalents | $1.74B | $1.58B | — |
| Total Debt (Short + Long Term) | $3.43B | $1.14B | $12.20B |
| Total Stockholders' Equity | $2.96B | $2.81B | $25.03B |